Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00566527
What this trial is testing

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,620
Early research (Phase 1)Study completedNCT00002383
What this trial is testing

A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT00196937
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 667
Testing effectiveness (Phase 2)Study completedNCT00798005
What this trial is testing

Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.

Who this might be right for
Severe Peripheral Artery Occlusive Disease
Sanofi 71
Testing effectiveness (Phase 2)Looking for participantsNCT05573802
What this trial is testing

Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasm, Plasma Cell+5 more
Hellenic Society of Hematology 36
Early research (Phase 1)Ended earlyNCT00497731
What this trial is testing

AZD1152 in Patients With Advanced Solid Malignancies-Study 1

Who this might be right for
Solid Tumors
AstraZeneca 70
Large-scale testing (Phase 3)Study completedNCT00345878
What this trial is testing

Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 271
Testing effectiveness (Phase 2)Study completedNCT04530552
What this trial is testing

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Who this might be right for
Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)Study completedNCT00129363
What this trial is testing

Study to Evaluate the Safety of Twice Daily Oral Carvedilol

Who this might be right for
Congestive Heart Failure
Shaddy, Robert, M.D. 75
Early research (Phase 1)Study completedNCT01666652
What this trial is testing

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults

Who this might be right for
Dengue Fever
U.S. Army Medical Research and Development Command 100
Early research (Phase 1)Study completedNCT01188252
What this trial is testing

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies

Who this might be right for
Neoplasms
Bayer 112
Early research (Phase 1)Study completedNCT00420485
What this trial is testing

Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 120
Early research (Phase 1)Study completedNCT00701324
What this trial is testing

BI 811283 in Various Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 124
Testing effectiveness (Phase 2)Study completedNCT00603668
What this trial is testing

Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL

Who this might be right for
Chronic Lymphocytic Lymphoma
Gilead Sciences 19
Testing effectiveness (Phase 2)Study completedNCT03942406
What this trial is testing

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

Who this might be right for
PertussisWhooping Cough
ILiAD Biotechnologies 300
Early research (Phase 1)Ended earlyNCT02138812
What this trial is testing

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Who this might be right for
Medical Oncology
Bayer 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078955
What this trial is testing

A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease

Who this might be right for
Dry Eye Disease (DED)Keratoconjunctivitis Sicca
BRIM Biotechnology Inc. 99
Large-scale testing (Phase 3)Study completedNCT00197171
What this trial is testing

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 143
Early research (Phase 1)Study completedNCT00613665
What this trial is testing

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

Who this might be right for
Helicobacter PyloriGastritisGastric Cancer+2 more
Novartis Vaccines 113
Early research (Phase 1)Study completedNCT00849732
What this trial is testing

A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)

Who this might be right for
HIV-1HIV Infections
Merck Sharp & Dohme LLC 360
Next Page